Here's A Better Pick Over Abbott Stock
forbes.com
news
2022-05-31 11:15:24

BRAZIL - 2022/05/15: In this photo illustration the Abbott Laboratories logo seen displayed on a ... [+] smartphone. (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images) SOPA Images/LightRocket via Getty Images 
We think that Teva stock (NYSE: TEVA) currently is a better pick compared to its industry peer, Abbott stock (NYSE: ABT), given its comparatively lower valuation and better prospects. TEVA stock is trading at 0.6x trailing revenues compared to 4.4x for Abbott. Even if we were to look at the P/EBIT ratio, ABT stock appears to be more expensive, with a 20.
